Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases

Arthritis and Rheumatism

Volumn 63, Issue 9, 2011, Pages 2547-2557

  MacDonald, Gordon I A ^a   Augello, Andrea ^a   De Bari, Cosimo ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; DOUBLE STRANDED DNA ANTIBODY; INTERLEUKIN 10; NEUTROPHIL CYTOPLASMIC ANTIBODY;

CELL FUNCTION; CELL POPULATION; CELL THERAPY; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TH1 CELL; TH17 CELL; TH2 CELL;

AUTOIMMUNE DISEASES; HUMANS; IMMUNE TOLERANCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RHEUMATIC DISEASES;

EID: 80052338976     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30474     Document Type: Review

References (53)

1. Petrie Aronin CE, Tuan RS,. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today 2010; 90: 67-74.
2. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis. Arthritis Rheum 2005; 52: 1595-603. (Pubitemid 40663952)
3. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G,. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007; 56: 1175-86. (Pubitemid 46608642)
4. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M,. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009; 60: 1006-19.
5. Schurgers E, Kelchtermans H, Mitera T, Geboes L, Matthys P,. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther 2010; 12: R31.
6. Park MJ, Park HS, Cho ML, Oh HJ, Cho YG, Min SY, et al. Transforming growth factor β-transduced mesenchymal stem cells ameliorate autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis. Arthritis Rheum 2011; 63: 1668-80.
7. Liu Y, Mu R, Wang S, Long L, Liu X, Li R, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 2010; 12: R210.
8. Bouffi C, Bony C, Courties G, Jorgensen C, Noel D,. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 2010; 5: e14247.
9. Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010; 69: 1423-9.
10. Augello A, Kurth TB, De Bari C,. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 2010; 20: 121-33.
11. Tyndall A, Gratwohl A,. Adult stem cell transplantation in autoimmune disease. Curr Opin Hematol 2009; 16: 285-91.
12. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41. (Pubitemid 38586721)
13. Martin I, Baldomero H, Tyndall A, Niederwieser D, Gratwohl A,. A survey on cellular and engineered tissue therapies in Europe in 2008. Tissue Eng Part A 2010; 16: 2419-27.
14. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP,. Heterotopic of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6: 230-47.
15. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7. (Pubitemid 29282067)
16. Chen FH, Tuan RS,. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008; 10: 223.
17. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP,. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001; 44: 1928-42. (Pubitemid 32758241)
18. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-7. (Pubitemid 44269669)
19. Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 2010; 12: 576-8.
20. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, et al, on behalf of Societe Francaise de Greffe de Moelle et Therapie Cellulaire. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010; 115: 1549-53.
21. Da Silva Meirelles L, Caplan AI, Nardi NB,. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008; 26: 2287-99.
22. Kurth TB, Dell'Accio F, Crouch V, Augello A, Sharpe PT, De Bari C,. Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis Rheum 2011; 63: 1289-300.
23. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 2005; 2: 47-57. (Pubitemid 40576763)
24. Bocelli-Tyndall C, Zajac P, Di Maggio N, Trella E, Benvenuto F, Iezzi G, et al., Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis Rheum 2010; 62: 3815-25.
25. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141-50. (Pubitemid 351181031)
26. Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R, et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 2005; 35: 1482-90. (Pubitemid 40691430)
27. Dudics V, Kunstar A, Kovacs J, Lakatos T, Geher P, Gomor B, et al. Chondrogenic potential of mesenchymal stem cells from patients with rheumatoid arthritis and osteoarthritis: measurements in a microculture system. Cells Tissues Organs 2009; 189: 307-16.
28. Jones E, Churchman SM, English A, Buch MH, Horner EA, Burgoyne CH, et al. Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level. Ann Rheum Dis 2010; 69: 450-7.
29. Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM,. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 2007; 16: 121-8. (Pubitemid 46347934)
30. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009; 27: 1421-32.
31. El-Badri NS, Hakki A, Ferrari A, Shamekh R, Good RA,. Autoimmune disease: is it a disorder of the microenvironment? Immunol Res 2008; 41: 79-86. (Pubitemid 351903814)
32. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA,. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-91. (Pubitemid 44674320)
33. Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 2008; 153: 269-76.
34. + mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin Exp Immunol 2010; 159: 292-302.
35. Rombouts WJ, Ploemacher RE,. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003; 17: 160-70. (Pubitemid 36175902)
36. Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar J, et al., Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol 2004; 31: 482-8. (Pubitemid 38337605)
37. Gonzalez-Rey E, Gonzalez MA, Varela N, O'Valle F, Hernandez-Cortes P, Rico L, et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 241-8.
38. Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, et al. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum 2010; 62: 2776-86.
39. Youd M, Blickarz C, Woodworth L, Touzjian T, Edling A, Tedstone J, et al. Allogeneic mesenchymal stem cells do not protect NZB×NZW F1 mice from developing lupus disease. Clin Exp Immunol 2010; 161: 176-86.
40. Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, et al. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 2010; 19: 1502-14.
41. Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 2008; 5: 417-24.
42. Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 2010; 19: 317-22.
43. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
44. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
45. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010; 62: 2467-75.
46. Van Paassen P, Duijvestijn A, Debrus-Palmans L, Damoiseaux J, Vroomen M, Tervaert JW,. Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy: a potential role for anti-endothelial cell antibodies. Ann N Y Acad Sci 2007; 1108: 147-56. (Pubitemid 47528728)
47. Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Fois E, et al. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 443-9. (Pubitemid 351498421)
48. Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, et al. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 2007; 56: 1994-2004. (Pubitemid 47110398)
49. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006; 54: 2605-15. (Pubitemid 44205023)
50. Christopeit M, Schendel M, Foll J, Mulle LP, Keysser G, Behre G,. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 2008; 22: 1062-4. (Pubitemid 351689891)
51. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
52. Romagnani S,. Human Th17 cells. Arthritis Res Ther 2008; 10: 206.
53. Olivito B, Simonini G, Ciullini S, Moriondo M, Betti L, Gambineri E, et al. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. J Rheumatol 2009; 36: 2017-24.